contents area
Press Release
detail content area
Investigation is undergoing in a Gangnam-gu medical facility due to cases with abnormal symptoms [May.9.(Wed), 2018]
- Date2018-05-09 17:20
- Update2019-11-18 20:00
- DivisionDivision of Public Health Preparedness and Response
- Tel043-719-7191
Investigation is undergoing in a Gangnam-gu medical facility due to cases with abnormal symptoms [May.9.(Wed), 2018]
□ On May 7, 2018, the Korea Centers for Disease Control and Prevention (KCDC) announced that multiple patients showed abnormal symptoms after having received treatments at a medical facility in Gangnam-gu, Seoul. The KCDC is investigating the event in collaboration with relevant ministries and agencies including Korea Ministry of Food and Drug Safety (KFDA), Seoul Metropolitan Government, Gangnam Community Health Center, Seoul Research Institute of Health and Environment and Seoul Gangnam Police Agency.
○ Among 29 outpatients of the facility on May 7, 20 developed symptoms of fever, low blood pressure, and nausea and all received propofol.
○ Of nine who have not shown any symptoms, one received propofol.
□ The KCDC is currently investigating healthcare workers in the facility regarding the relevant procedures and medical records of 29 outpatients on May 7th.
○ The Seoul provincial government and the Gangnamgu health post is monitoring the symptoms of outpatients since May 1st and KFDA collected the product and the test is underway.
○ 41 samples including used vials, propofols and syringes were collected to conduct laboratory confirmation in the Seoul Research institute of Health and Environment. Blood culture of the admitted cases is also undergoing.
※ Information in the release can be updated when additional information is available
□ On May 7, 2018, the Korea Centers for Disease Control and Prevention (KCDC) announced that multiple patients showed abnormal symptoms after having received treatments at a medical facility in Gangnam-gu, Seoul. The KCDC is investigating the event in collaboration with relevant ministries and agencies including Korea Ministry of Food and Drug Safety (KFDA), Seoul Metropolitan Government, Gangnam Community Health Center, Seoul Research Institute of Health and Environment and Seoul Gangnam Police Agency.
○ Among 29 outpatients of the facility on May 7, 20 developed symptoms of fever, low blood pressure, and nausea and all received propofol.
○ Of nine who have not shown any symptoms, one received propofol.
□ The KCDC is currently investigating healthcare workers in the facility regarding the relevant procedures and medical records of 29 outpatients on May 7th.
○ The Seoul provincial government and the Gangnamgu health post is monitoring the symptoms of outpatients since May 1st and KFDA collected the product and the test is underway.
○ 41 samples including used vials, propofols and syringes were collected to conduct laboratory confirmation in the Seoul Research institute of Health and Environment. Blood culture of the admitted cases is also undergoing.
※ Information in the release can be updated when additional information is available
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions